Outcomes of immune checkpoint inhibitor rechallenge in relapsed/refractory Hodgkin lymphoma∗

ABSTRACT:

SUBMITTER: Nishimura Y 

PROVIDER: S-EPMC12346057 | biostudies-literature | 2025 Jul

REPOSITORIES: biostudies-literature